An interdisciplinary research team from two working groups at the Center for Synthetic Biology at TU Darmstadt has developed ...

An interdisciplinary research team from two working groups at the Centre for Synthetic Biology at TU Darmstadt has developed the first RNA-based genetic switch that precisely replicates the logical ...

We caught up with the authors of a new book on the applications of nanomedicine in cancer to get their inside line on the book and its topic.

RNA therapeutics target translation rather than DNA, aiming to correct shared protein production errors. By enabling cells to read through premature stop codons, engineered tRNAs could restore ...

An important study has uncovered an unexpected molecular player that helps make cancer cells stress-resilient, thereby promoting the survival, growth and progression of tumours. Researchers have ...

RTX-117 is an investigational small molecule designed to modulate the Integrated Stress Response (ISR) pathway, with the goal ...

Scientists have identified a critical breakdown in the cellular machinery that produces proteins in aging brains.

Each year, approximately 36,000 people are diagnosed with the disease in the United States, according to the American Cancer ...

Q4 2025 Earnings Call February 26, 2026 8:30 AM ESTCompany ParticipantsKate Rausch - Head of Investor RelationsPaul Bolno ...

Structural nanomedicine — what helped give us the COVID vaccine — may now be the key to a potent blood cancer treatment that’s had remarkable early results.

Integrated Workflow Including Clinical Seed Production and StemEdit Gene Editing ServicesBELTSVILLE, Md., March 3, 2026 /PRNewswire/ -- REPROCELL (TYO: 4978) today announced the launch of its ...